- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-702/21 P: Judgment of the Court (Eighth Chamber) of 10 November 2022 — Laboratoire Pareva v Biotech3D Ltd & Co. KG, European Commission, French Republic, European Chemicals Agency (Appeal — Biocidal products — Regulation (EU) No 528/2012 — Delegated Regulation (EU) No 1062/2014 — Active substance PHMB (1415; 4.7) — Refusal of approval as an existing active substance for use in biocidal products of product-types 1, 5 and 6 — Approval as an existing active substance for use in biocidal products of product-types 2 and 4 — Teratogenic effect — Human health risk assessment)
ECLI:EU:UNKNOWN:62021CA0702
62021CA0702
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
9.1.2023
Official Journal of the European Union
C 7/13
(Case C-702/21 P)
(Appeal - Biocidal products - Regulation (EU) No 528/2012 - Delegated Regulation (EU) No 1062/2014 - Active substance PHMB (1415; 4.7) - Refusal of approval as an existing active substance for use in biocidal products of product-types 1, 5 and 6 - Approval as an existing active substance for use in biocidal products of product-types 2 and 4 - Teratogenic effect - Human health risk assessment)
(2023/C 7/15)
Language of the case: English
Parties
Appellant: Laboratoire Pareva (represented by S. Englebert, M. Grunchard and M. Ombredane, avocats, P. Sellar, advocaat, and by K. Van Maldegem, avocat)
Other parties to the proceedings: Biotech3D Ltd & Co. KG, European Commission (represented by R. Lindenthal and K. Mifsud-Bonnici, acting as Agents), French Republic (represented by G. Bain and J.-L. Carré, acting as Agents), European Chemicals Agency (ECHA) (represented by C. Buchanan, M. Heikkilä and T. Zbihlej, acting as Agents)
Operative part of the judgment
The Court:
1.Dismisses the appeal;
2.Orders Laboratoire Pareva to pay the costs;
3.Orders the French Republic to bear its own costs.
(1)
OJ C 64, 7.2.2022.